{"changes":[],"country":"US","description":"Pearl Bio uses genome and ribosome engineering to manufacture biologics with non-canonical amino acids and novel chemistries. It serves pharma partners looking for protein-drug formats outside what natural ribosomes can build. A $1B collaboration with Merck for engineered cancer biologics is the kind of platform deal narrow-spectrum protein-engineering shops rarely attract.","domain":"pearlbio.com","employees":null,"founded":2020,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"medtech","investors":["khosla"],"lat":38.895098,"lng":-77.036385,"location":"Washington, DC","name":"Pearl Bio","rounds":[{"amountQuarantined":false,"amountUsd":1000000,"currency":"USD","date":"2024-01-01","investors":["khosla"],"leadInvestor":"khosla","source":{"fact":"round","publisher":"vc-portfolio","retrievedAt":"2026-05-07","status":"attributed","url":null},"status":"attributed","type":"series-a","url":null}],"slug":"pearlbio-com","sources":[{"fact":"round","publisher":"vc-portfolio","retrievedAt":"2026-05-07","status":"attributed","url":null},{"fact":"existence","publisher":"pearlbio.com","retrievedAt":"2026-05-07","status":"self-reported","url":"https://pearlbio.com"},{"fact":"description","publisher":"pearlbio.com","retrievedAt":"2026-05-07","status":"self-reported","url":"https://pearlbio.com"}],"stage":"series-a","techStack":["Cloudflare","All in One SEO 4.4.3","All in One SEO Pack 4.4.3","Kinsta","Google Analytics","Google Tag Manager","Font Awesome","jQuery Migrate 3.4.1","Elementor 3.13.4","Elementor Addon Elements 1.1.0","particles.js","DoubleClick Floodlight"],"totalRaisedUsd":1000000,"updatedAt":"2026-05-07"}